It is not currently possible to quantify the amount of investment across all areas of pancreatic cancer research, which can span clinical trials, epidemiological studies of causes and outcomes, and laboratory based research. The funding sources for such research include the Health Research Board and Science Foundation Ireland, cancer charities and pharmaceutical company funded clinical trials.
In line with the National Cancer Strategy 2017-2026, a National Cancer Research Group is currently being established. The Group will improve co-ordination and oversight of cancer research nationally and provide a forum for the agreement of research priorities. The Group will also seek to achieve continuity of funding and to ensure that funding allocations are linked to the agreed research priorities.